Steven U. Walkley
board member
AngioChem
Canada
Biography
Dr. Steven Walkley is Professor of Neuroscience, Pathology and Neurology and Director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center at the Albert Einstein College of Medicine. His research efforts are focused on lysosomal diseases affecting the brain, an interest that began during his early training in Comparative Medicine and Neuroscience. He has published extensively in the area of pathogenic cascade analysis in lysosomal disease, defining key changes in neuronal structure and function as a consequence of lysosomal compromise. Dr. Walkley’s lab has also been at the forefront of new treatments for these disorders, including the development of the first and presently only approved therapy for Niemann-Pick type C disease. Dr. Walkley was a co-founder of the newly developed Gordon Research Conference on Lysosomal Diseases and is an active member of the scientific advisory boards for numerous lysosomal disease organizations.
Research Interest
neurology
